HomeASBP • NASDAQ
Aspire Biopharma Holdings Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 242.62K | -25.29% |
Net income | -537.02K | -719.44% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -0.42% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.54K | 5,807.50% |
Total assets | 184.04K | -99.07% |
Total liabilities | 13.17M | -33.99% |
Total equity | -801.59K | — |
Shares outstanding | 443.32M | — |
Price to book | -0.72 | — |
Return on assets | -23.31% | — |
Return on capital | 184.34% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -537.02K | -719.44% |
Cash from operations | -533.80K | -76.58% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 492.48K | 177.80% |
Net change in cash | -3.06K | 97.55% |
Free cash flow | 236.54K | 7,625.93% |
Previous close
$0.61
Day range
$0.57 - $0.60
Year range
$0.53 - $15.80
Market cap
26.92M USD
Avg Volume
908.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website
